| abstract |
The invention concerns the field of the necessities of life and more particularly the field of therapeutics. More particularly, it concerns pharmaceutical compositions for a return to abstinence of users of addictive drugs in the form of a combination of two drugs consisting of a partial or total ligand of dopaminergic receptors, in particular D1, D2 and D3 receptors, and having a direct prodopaminergic activity and an indirect prodopaminergic product, in the form of a pharmaceutical composition for oral, parenteral or transdermal administration. The invention also concerns a method for fighting against various forms of addiction to legal or illegal drugs. |